Oxford Medical Diagnostics, a UK developer of breath based, medical diagnostic technology for the diagnosis and monitoring of metabolic and infectious diseases; and V&F Analyse- und Messtechnik, an Austrian provider of analytical instruments, announced a strategic alliance focusing on the area of mass spectrometry.
Oxford Medical Diagnostics, a UK developer of breath based, medical diagnostic technology for the diagnosis and monitoring of metabolic and infectious diseases; and V&F Analyse- und Messtechnik, an Austrian provider of analytical instruments, announced a strategic alliance focusing on the area of mass spectrometry.
Under the terms of the new agreement, Oxford Medical Diagnostics will offer and support V&F’s high-performance mass spectrometry analysers in the UK and Ireland and establish a contract batch sample analysis service in its Oxford laboratories.
“This is a great alliance for OMD, linking us to one of the most talented molecular analysis companies in the world. It brings analytical know-how, and the opportunity to earn revenues,” said Oxford Medical Diagnostics CEO, Tony Marchington.
Target markets for the technology and analytical services include pharmaceutical, biotechnology, aerospace, fine chemicals, oil and gas, environmental and food and beverage analysis. OMD currently uses V&F’s technology to compare clinical results from diabetic patients with OMD’s proprietary laser-based breath analysis solutions.
In addition to this collaboration, the two companies report that they are looking into other opportunities for joint research. These include bacterial headspace analysis, as well as sports performance monitoring and healthy weight loss management.
For more information visit omdiagnostics.com and www.vandf.com
Unlocking Metabolic Mysteries: Glioma Tumor Spheroids' Biochemical Blueprint Revealed
March 18th 2024In a recent study, researchers from the Chinese Academy of Medical Sciences and Peking Union Medical College used liquid chromatography–mass spectrometry (LC–MS) to gain further insight into tumor metabolism.
Transferring Methods to Compact and Portable HPLC
February 14th 2024The current trend in laboratory equipment design is the miniaturization of laboratory instruments. Smaller-scale HPLC instruments offer benefits that cannot be matched by analytical-scale equipment, especially in the areas of portability, reduced fluid volumes, and reduced operating costs. Yet, the miniaturization of laboratory equipment has brought with it a unique set of challenges, including transferring methods to compact LC. Capillary LC expands the use of LC to applications not currently done using conventional LC in a wide array of application areas, including pharmaceutical, food and beverage, petrochemical, environmental, and oil and gas. Greg Ward, Axcend’s CEO wrote, “Customers want an HPLC system with a small footprint, low flow rates and green chemistry.” Join his podcast where he shares method transfer in these application areas.